Pharmamarketeer

UK halts trial of hydroxychloroquine as ‘useless’ for COVID-19 patients

British scientists halted a major drug trial on Friday after it found that the anti-malarial hydroxychloroquine, touted by U.S. President Donald Trump as a potential “game changer” in the pandemic, was “useless” at treating COVID-19 patients.

Medhc-fases-banner
Advertentie(s)